These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30040140)

  • 61. Impact of bisphosphonate compliance on the risk of osteoporotic fracture in France.
    Belhassen M; Cortet B; Confavreux CB; Lamezec L; Ginoux M; Van Ganse E
    Arch Osteoporos; 2018 Oct; 13(1):113. PubMed ID: 30341636
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of the implementation of a Fracture Liaison Service on pharmaceutical expenses for osteoporosis compared to an area without an FLS.
    Naranjo A; Ojeda-Bruno S; Saavedra A; Molina A; Negrín M
    Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):81-87. PubMed ID: 30129375
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Patients not taking a previously prescribed bone active medication now prescribed medication through Ontario FLS.
    Sale JEM; Yang A; Inrig T; Gandhi S; Elliot-Gibson V; Sujic R; Jain R; Weldon J; Linton D; Bogoch E
    Osteoporos Int; 2022 Nov; 33(11):2435-2440. PubMed ID: 35763074
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
    Segaud N; Legroux I; Hazzan M; Noel C; Cortet B
    Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
    Miller PD; Hattersley G; Riis BJ; Williams GC; Lau E; Russo LA; Alexandersen P; Zerbini CA; Hu MY; Harris AG; Fitzpatrick LA; Cosman F; Christiansen C;
    JAMA; 2016 Aug; 316(7):722-33. PubMed ID: 27533157
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Randomised trial assessing the impact of framing of fracture risk and osteoporosis treatment benefits in patients undergoing bone densitometry.
    Kalluru R; Petrie KJ; Grey A; Nisa Z; Horne AM; Gamble GD; Bolland MJ
    BMJ Open; 2017 Feb; 7(2):e013703. PubMed ID: 28188155
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improvement of osteoporosis Care Organized by Nurses: ICON study - Protocol of a quasi-experimental study to assess the (cost)-effectiveness of combining a decision aid with motivational interviewing for improving medication persistence in patients with a recent fracture being treated at the fracture liaison service.
    Cornelissen D; Boonen A; Evers S; van den Bergh JP; Bours S; Wyers CE; van Kuijk S; van Oostwaard M; van der Weijden T; Hiligsmann M
    BMC Musculoskelet Disord; 2021 Oct; 22(1):913. PubMed ID: 34715838
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.
    Wang CC; Lu HT; Dusetzina SB; Wu CH
    J Womens Health (Larchmt); 2016 Jul; 25(7):738-46. PubMed ID: 27096405
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Value of a coordinated management of osteoporosis via Fracture Liaison Service for the treatment of orthogeriatric patients.
    Schray D; Neuerburg C; Stein J; Gosch M; Schieker M; Böcker W; Kammerlander C
    Eur J Trauma Emerg Surg; 2016 Oct; 42(5):559-564. PubMed ID: 27458065
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Influence of fracture history and bone mineral density testing on the treatment of osteoporosis in two non-academic community centers.
    Hamel ME; Sebaldt RJ; Siminoski K; Adachi JD; Papadimitropoulos E; Petrie A; Goldsmith CH
    Osteoporos Int; 2005 Feb; 16(2):208-15. PubMed ID: 15517185
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Zoledronic acid increases bone mineral density and improves health-related quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis.
    Huang S; Lin H; Zhu X; Chen X; Fan L; Liu C
    Endokrynol Pol; 2014; 65(2):96-104. PubMed ID: 24802732
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of Abaloparatide-SC on Fractures and Bone Mineral Density in Subgroups of Postmenopausal Women With Osteoporosis and Varying Baseline Risk Factors.
    Cosman F; Hattersley G; Hu MY; Williams GC; Fitzpatrick LA; Black DM
    J Bone Miner Res; 2017 Jan; 32(1):17-23. PubMed ID: 27612281
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Patient Healthcare Trajectory and its Impact on the Cost-Effectiveness of Fracture Liaison Services.
    Senay A; Fernandes JC; Delisle J; Morin SN; Dragomir A; Nazha S; Perreault S
    J Bone Miner Res; 2021 Mar; 36(3):459-468. PubMed ID: 33484586
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The LIFTMOR-M (Lifting Intervention For Training Muscle and Osteoporosis Rehabilitation for Men) trial: protocol for a semirandomised controlled trial of supervised targeted exercise to reduce risk of osteoporotic fracture in older men with low bone mass.
    Harding AT; Weeks BK; Watson SL; Beck BR
    BMJ Open; 2017 Jun; 7(6):e014951. PubMed ID: 28611110
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice.
    Pencille LJ; Campbell ME; Van Houten HK; Shah ND; Mullan RJ; Swiglo BA; Breslin M; Kesman RL; Tulledge-Scheitel SM; Jaeger TM; Johnson RE; Bartel GA; Wermers RA; Melton LJ; Montori VM
    Trials; 2009 Dec; 10():113. PubMed ID: 20003299
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Geisinger high-risk osteoporosis clinic (HiROC): 2013-2015 FLS performance analysis.
    Dunn P; Webb D; Olenginski TP
    Osteoporos Int; 2018 Feb; 29(2):451-457. PubMed ID: 29063214
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2014 Jul; (7):CD005088. PubMed ID: 25054949
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical effect of early bisphosphonate treatment for pyogenic vertebral osteomyelitis with osteoporosis: An analysis by the Cox proportional hazard model.
    Kim J; Jang SB; Kim SW; Oh JK; Kim TH
    Spine J; 2019 Mar; 19(3):418-429. PubMed ID: 30172897
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system.
    Solomon DH; Patrick AR; Schousboe J; Losina E
    J Bone Miner Res; 2014 Jul; 29(7):1667-74. PubMed ID: 24443384
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long-term persistence of treatment after hip fracture in a fracture liaison service.
    Naranjo A; Molina A; Quevedo A; Rubiño FJ; Sánchez-Alonso F; Rodríguez-Lozano C; Ojeda S
    Sci Rep; 2022 Jun; 12(1):9373. PubMed ID: 35672434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.